Inventor · disambiguated record
Noel Terrence Southall
Also filed as: SOUTHALL NOEL · SOUTHALL NOEL T · SOUTHALL NOEL TERRENCE
25 granted patents·12 pending applications·96 citations·filing 2008–2025
94Inventor score
Files withUS HEALTH15THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES3MARUGAN JUAN JOSE2THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE2UNIV JOHNS HOPKINS2
Top patents by PatentIndex Score
37 records- 0196US9044451B2Use of delta tocopherol for the treatment of lysosomal storage disordersZHENG WEI·Filed 2011·Granted Jun 2, 2015·36 cites·18 claims
- 0290US9353117B2Substituted pyrazolopyrimidines as glucocerebrosidase activatorsMARUGAN JUAN JOSE·Filed 2011·Granted May 31, 2016·25 cites·26 claims
- 0385US9550742B211-OXO-10,11-dihydrodibenzo[B,F][1,4]thiazepine S-oxide derivatives and their use as dopamine D2 receptor antagonistsTHE US SECRETARY DEPT OF HEALTH AND HUMAN·Filed 2014·Granted Jan 24, 2017·21 cites·22 claims
- 0483US11253511B2Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)UNIV JOHNS HOPKINS·Filed 2017·Granted Feb 22, 2022·2 cites·4 claims
- 0577US9663521B2Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesisUS HEALTH·Filed 2012·Granted May 30, 2017·3 cites·19 claims
- 0677US9446048B2Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteinsLIU PU·Filed 2012·Granted Sep 20, 2016·4 cites·13 claims
- 0777US2024316056A1Formulations and methods for the prevention and treatment of tumor metastasis and tumorigenesisUS HEALTH·Filed 2024·Application pending·0 cites
- 0876US2025340521A1C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2025·Application pending·0 cites
- 0975US9974789B2Substituted pyrazolopyrimidines as glucocerebrosidase activatorsTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN·Filed 2016·Granted May 22, 2018·2 cites·20 claims
- 1073US12435047B2c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Oct 7, 2025·0 cites·19 claims
- 1172US10301314B2Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesisUS HEALTH·Filed 2017·Granted May 28, 2019·1 cites·9 claims
- 1271US12145922B2Selective D3 dopamine receptor agonists and methods of their useUS HEALTH·Filed 2023·Granted Nov 19, 2024·0 cites·21 claims
- 1371US9452973B2Modulators of the relaxin receptor 1THE US SECRETARY DEPT OF HEALTH AND HUMAN SERVICE·Filed 2013·Granted Sep 27, 2016·1 cites·18 claims
- 1470US12208093B2Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)UNIV JOHNS HOPKINS·Filed 2022·Granted Jan 28, 2025·0 cites·4 claims
- 1564US9464035B2Salicylic acid derivatives useful as glucocerebrosidase activatorsUS HEALTH·Filed 2013·Granted Oct 11, 2016·1 cites·11 claims
- 1662US10925874B2Substituted pyrazolopyrimidines as glucocerebrosidase activatorsTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2018·Granted Feb 23, 2021·0 cites·18 claims
- 1760US9296729B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsUS HEALTH·Filed 2014·Granted Mar 29, 2016·0 cites·38 claims
- 1859US2021186972A1Formulations and methods for the prevention and treatment of tumor metastasis and tumorigenesisTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2019·Application pending·0 cites
- 1959US2025134907A1Fused diazepines as agonists of the insulin-like 3 (insl3) peptide receptor rxfp2 and methods of use thereofUS HEALTH·Filed 2023·Application pending·0 cites
- 2058US11649218B2C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the sameTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted May 16, 2023·0 cites·18 claims
- 2158US9187457B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsUS HEALTH·Filed 2013·Granted Nov 17, 2015·0 cites·21 claims
- 2257US8741259B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsGERSHENGORN MARVIN C·Filed 2008·Granted Jun 3, 2014·0 cites·28 claims
- 2356US10039741B2Use of delta tocopherol for the treatment of lysosomal storage disordersTHE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES·Filed 2016·Granted Aug 7, 2018·0 cites·20 claims
- 2456US9458141B2Low molecular weight thyroid stimulating hormone receptor (TSHR) agonistsUS HEALTH·Filed 2015·Granted Oct 4, 2016·0 cites·7 claims
- 2555US11634404B2Selective D3 dopamine receptor agonists and methods of their useUS HEALTH·Filed 2017·Granted Apr 25, 2023·0 cites·16 claims
- 2655US2015265571A1Use of delta tocopherol for the treatment of lysosomal storage disordersUS HEALTH·Filed 2015·Application pending·0 cites
- 2754US2024336604A1D3 dopamine receptor-selective negative allosteric modulatorsUS HEALTH·Filed 2022·Application pending·0 cites
- 2853US10125112B2Modulators of the relaxin receptor 1THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICE·Filed 2016·Granted Nov 13, 2018·0 cites·3 claims
- 2952US2022315548A1Small molecule agonists of mucolipin 1 and uses thereofUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 3049US9173898B2Methods of treating giardiasisZHENG WEI·Filed 2011·Granted Nov 3, 2015·0 cites·1 claims
- 3144US2023056497A1CD206 Modulators Their Use and Methods for PreparationUS HEALTH·Filed 2020·Application pending·0 cites
- 3244US2014155420A1Inhibitors of eya2ZHAO RUI·Filed 2012·Application pending·0 cites
- 3342US2017001988A1Piperidine and piperazine derivatives and their use in treating viral infections and cancerUS HEALTH·Filed 2014·Application pending·0 cites
- 3441US2021040074A1Positive allosteric modulators of dopamine 1 receptor and method of use thereofSIBLEY DAVID R·Filed 2019·Application pending·0 cites
- 3534US2013096160A1Arylthiazolyl piperidines and related compounds as modulators of survival motor neuron (smn) protein productionMARUGAN JUAN JOSE·Filed 2011·Application pending·0 cites
- 3632US10202367B2Heterocyclic compounds and methods of use thereofUS HEALTH·Filed 2015·Granted Feb 12, 2019·0 cites·6 claims
- 3731US10239830B2Benzenesulfonamide upregulators of NPC1 for Neimann-Pick disease and other lysosomal storage disordersICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Granted Mar 26, 2019·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Noel Terrence Southall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →